New Kidney Disease Therapies Strike at the Root of IgA Nephropathy
A new review maps how mechanism-based therapies targeting galactose-deficient IgA1 are transforming IgA nephropathy treatment, from mucosal interventions to APRIL ...
A new review maps how mechanism-based therapies targeting galactose-deficient IgA1 are transforming IgA nephropathy treatment, from mucosal interventions to APRIL ...
A real-world study of 28 patients found that Nefecon reduced proteinuria by 55.8 percent and improved kidney function in IgA ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine